An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) will host its first quarter 2024 investor update conference call and webcast on May 9, 2024, at 8:30 a.m. Eastern Time. Participants can join the call by dialing (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) with conference ID number and event passcode 3416473. The webcast can be accessed on Ironwood's website. The call will be available for replay via telephone and webcast.
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) organizzerà la conferenza telefonica e il webcast per l'aggiornamento degli investitori del primo trimestre del 2024 il 9 maggio 2024 alle 8:30, ora della costa orientale. I partecipanti possono unirsi alla conferenza telefonando al (888) 596-4144 (Stati Uniti e Canada) o al (646) 968-2525 (internazionale), usando il codice di conferenza e il codice di accesso all'evento 3416473. Il webcast sarà accessibile sul sito web di Ironwood. Sarà possibile riascoltare la chiamata tramite telefono e webcast.
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) será el anfitrión de la conferencia telefónica y el webcast de la actualización para inversores del primer trimestre de 2024 el 9 de mayo de 2024 a las 8:30 a.m., hora del este. Los participantes pueden unirse a la llamada marcando el (888) 596-4144 (EE. UU. y Canadá) o el (646) 968-2525 (internacional) con el número de ID de conferencia y el código de acceso al evento 3416473. El webcast se puede acceder en el sitio web de Ironwood. La llamada estará disponible para ser reproducida por teléfono y webcast.
아이언우드 파마슈티컬스(Ironwood Pharmaceuticals) 주식회사 (Nasdaq: IRWD) 는 2024년 5월 9일 오전 8시 30분 (동부 표준시)에 2024년 1분기 투자자 업데이트 컨퍼런스 콜과 웹 캐스트를 개최할 예정입니다. 참가자는 전화번호 (888) 596-4144 (미국 및 캐나다) 또는 (646) 968-2525 (국제)으로 전화하고 회의 ID 번호 및 행사 패스코드 3416473을 입력하여 참여할 수 있습니다. 웹캐스트는 아이언우드의 웹사이트에서 접속할 수 있습니다. 전화와 웹캐스트를 통해 회의를 다시 들을 수 있습니다.
Ironwood Pharmaceuticals, Inc. (Nasdaq : IRWD) tiendra une conférence téléphonique et un webcast pour la mise à jour des investisseurs du premier trimestre 2024 le 9 mai 2024 à 8h30, heure de l'Est. Les participants peuvent rejoindre l'appel en composant le (888) 596-4144 (États-Unis et Canada) ou le (646) 968-2525 (international) avec le numéro d'identification de la conférence et le code d'accès à l'événement 3416473. Le webcast peut être accédé sur le site Web d'Ironwood. L'appel sera disponible en rediffusion par téléphone et webcast.
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) wird am 9. Mai 2024 um 8:30 Uhr Ostküstenzeit das Webcast und die Telefonkonferenz zum Investorenupdate für das erste Quartal 2024 abhalten. Teilnehmer können sich über die Telefonnummern (888) 596-4144 (USA und Kanada) oder (646) 968-2525 (international) unter Angabe der Konferenz-ID und des Ereignispasscodes 3416473 einwählen. Das Webcast ist über die Website von Ironwood zugänglich. Der Anruf kann über Telefon und Webcast erneut abgespielt werden.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event passcode 3416473. To access the webcast, please visit the Investors section of Ironwood’s website at www.ironwoodpharma.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.
The call will be available for replay via telephone starting Thursday, May 9, 2024 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on Thursday, May 23, 2024. To listen to the replay, dial (800) 770-2030 (U.S. and Canada) or (609) 800-9909 (international) using conference ID number 3416473. The archived webcast will be available on Ironwood’s website for 1 year beginning approximately one hour after the call has completed.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, with a site in Basel, Switzerland.
We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.
When will Ironwood Pharmaceuticals host its first quarter 2024 investor update conference call and webcast?
Ironwood Pharmaceuticals will host its first quarter 2024 investor update conference call and webcast on May 9, 2024, at 8:30 a.m. Eastern Time.
How can individuals participate in the call?
Individuals can participate in the call by dialing (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) with conference ID number and event passcode 3416473.
Where can the webcast be accessed?
The webcast can be accessed on Ironwood's website in the Investors section.
How long will the call be available for replay via telephone?
The call will be available for replay via telephone starting Thursday, May 9, 2024, at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on Thursday, May 23, 2024.
For how long will the archived webcast be available on Ironwood's website?
The archived webcast will be available on Ironwood's website for 1 year beginning approximately one hour after the call has completed.
ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b
